Clinical trial
Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
NCT05674786 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
- Lead sponsor
- Johns Hopkins University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 28, 2023
- Completion date
- March 31, 2027
- Enrollment
- 8 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aminoglycoside ototoxicity, bilateral vestibular deficiency (bvd), bilateral vestibular hypofunction, bilateral vestibulopathy, gentamicin ototoxicity, labyrinth diseases, other disorders of vestibular function, bilateral, sensation disorders, vestibular diseases